UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006631 |
|---|---|
| Receipt number | R000007842 |
| Scientific Title | Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamide |
| Date of disclosure of the study information | 2011/11/01 |
| Last modified on | 2020/01/23 23:00:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/10/29 22:53:38 | ||
| 2 | Update | 2020/01/20 07:20:13 | Target sample size |
|
| 3 | Update | 2020/01/21 11:16:01 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code TEL Last name of contact person Last name of contact person Zip code TEL Name of primary person or sponsor Organization Organization Organization Category of Funding Organization Organization Organization Address Address Tel |
|
| 4 | Update | 2020/01/21 11:20:13 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2020/01/21 11:20:46 | Number of participants that the trial has enrolled |
|
| 6 | Update | 2020/01/21 11:24:48 | Tel1 Email1 |
|
| 7 | Update | 2020/01/21 11:29:05 | Condition Condition |
|
| 8 | Update | 2020/01/21 11:30:22 | ||
| 9 | Update | 2020/01/21 11:46:27 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 10 | Update | 2020/01/21 22:54:30 | Key secondary outcomes Key secondary outcomes |
|
| 11 | Update | 2020/01/23 23:00:15 | Key exclusion criteria Key exclusion criteria |
|
| 12 | Update | 2020/01/23 23:00:41 | Key exclusion criteria |
